Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers


  Free Subscription

Articles published in Hemoglobin

Retrieve available abstracts of 218 articles:
HTML format

Single Articles

    June 2021
  1. ANAH MU, Nlemadim AC, Uzomba CI, Ineji EO, et al
    Prolonged QTc Interval in Nigerian Children with Sickle Cell Anemia.
    Hemoglobin. 2021 Jun 10:1-6. doi: 10.1080/03630269.2021.1937207.
    PubMed     Abstract available

    May 2021
  2. ZHAO Q, Zhao SM, Zhang X, Chen SP, et al
    Detection of the HBB: c.393T>G Mutation in Two Patients with Hypochromic Microcytic Anemia.
    Hemoglobin. 2021 May 25:1-4. doi: 10.1080/03630269.2021.1929307.
    PubMed     Abstract available

    March 2021
  3. ALIMOHAMMADI-BIDHENDI S, Azadmehr S, Razipour M, Zeinali S, et al
    Regulatory Mutation Study in Cases with Unsolved Hypochromic Microcytic Anemia and alpha-Major Regulatory Element Haplotype Analysis in Iran.
    Hemoglobin. 2021 Mar 27:1-4. doi: 10.1080/03630269.2021.1882482.
    PubMed     Abstract available

    January 2021
  4. MEHER S, Mohanty PK, Patel S, Das K, et al
    Haptoglobin Genotypes Associated with Vaso-Occlusive Crisis in Sickle Cell Anemia Patients of Eastern India.
    Hemoglobin. 2021 Jan 3:1-7. doi: 10.1080/03630269.2020.1801459.
    PubMed     Abstract available

  5. ZAFARI M, Rad MTS, Mohseni F, Nikbakht N, et al
    beta-Thalassemia Major and Coronavirus-19, Mortality and Morbidity: a Systematic Review Study.
    Hemoglobin. 2021;45:1-4.
    PubMed     Abstract available

    November 2020
  6. CHOURASIA S, Kumar R, Singh MPSS, Vishwakarma C, et al
    High Prevalence of Anemia and Inherited Hemoglobin Disorders in Tribal Populations of Madhya Pradesh State, India.
    Hemoglobin. 2020 Nov 22:1-10. doi: 10.1080/03630269.2020.1848859.
    PubMed     Abstract available

    July 2020
  7. BALANCHIVADZE N, Kudirka AA, Askar S, Almadhoun K, et al
    Impact of COVID-19 Infection on 24 Patients with Sickle Cell Disease. One Center Urban Experience, Detroit, MI, USA.
    Hemoglobin. 2020;44:284-289.
    PubMed     Abstract available

    May 2020
  8. PINTO VM, Derchi GE, Bacigalupo L, Pontali E, et al
    COVID-19 in a Patient with beta-Thalassemia Major and Severe Pulmonary Arterial Hypertension.
    Hemoglobin. 2020;44:218-220.
    PubMed     Abstract available

    March 2020
  9. TERAN MM, Monaco ME, Lazarte SS, Haro C, et al
    Genetic Regulation of Redox Balance in beta-Thalassemia Trait.
    Hemoglobin. 2020;44:122-127.
    PubMed     Abstract available

  10. AL-ALI AK, Alsulaiman A, Alzahrani AJ, Obeid OT, et al
    Prevalence and Diversity of Haplotypes of Sickle Cell Disease in the Eastern Province of Saudi Arabia.
    Hemoglobin. 2020;44:78-81.
    PubMed     Abstract available

  11. AZIMI A, Tahmasebi S, Moradi K, Nejati P, et al
    Severe alpha-Thalassemia Due to Compound Heterozygosity for Hb Adana (alpha59 Gly>Asp) (HBA1: c.179G > A) and Codon 127 (A > T) (HBA2: c.382A > T) in an Iranian Family.
    Hemoglobin. 2020;44:139-142.
    PubMed     Abstract available

  12. HORRI-NACEUR A, Timson DJ
    In Silico Analysis of the Effects of Point Mutations on alpha-Globin: Implications for alpha-Thalassemia.
    Hemoglobin. 2020;44:89-103.
    PubMed     Abstract available

  13. SAMHA L, Sirdah MM, Reading NS, Karmi B, et al
    Molecular Understanding of Severe Cases of beta-Thalassemia in the Nablus Region, West Bank, Palestine.
    Hemoglobin. 2020;44:128-130.
    PubMed     Abstract available

  14. AKSU T, Coskun C, Kuskonmaz B, Unal S, et al
    Hb H Disease Diagnosed During Adolescent Pregnancy.
    Hemoglobin. 2020;44:137-138.
    PubMed     Abstract available

  15. AZARKEIVAN A, Cohan N, Niazkar HR, Azizi A, et al
    Hb S (HBB: c.20A>T) and alpha- and beta-Thalassemia Coinheritance in Iranian Patients.
    Hemoglobin. 2020;44:109-112.
    PubMed     Abstract available

  16. HALDER R, Sundaram UKD, Veetil KK, Rath A, et al
    Concomitant Existence of Paroxysmal Nocturnal Hemoglobinuria in a Patient with Hb E (HBB: c.79G>A) Trait.
    Hemoglobin. 2020;44:134-136.
    PubMed     Abstract available

  17. JIANG F, Xu LL, Chen GL, Zhou JY, et al
    Hematological Characteristics of Hb Constant Spring (HBA2: c.427T>C) Carriers in Mainland China.
    Hemoglobin. 2020;44:86-88.
    PubMed     Abstract available

  18. MANCO L, Bento C, Relvas L, Cunha E, et al
    Multi-Locus Models to Address Hb F Variability in Portuguese beta-Thalassemia Carriers.
    Hemoglobin. 2020;44:113-117.
    PubMed     Abstract available

  19. AL-NOOD HA, Al-Nood RM, Ghanem NS, Al-Hadi AM, et al
    Effect of the Hydoxyurea in Yemeni Transfusion-Dependent beta-Thalassemia Patients.
    Hemoglobin. 2020;44:104-108.
    PubMed     Abstract available

  20. ALASHKAR F, Herbstreit F, Carpinteiro A, Baum J, et al
    Veno-Venous Extracorporeal Membrane Oxygenation in Adult Patients with Sickle Cell Disease and Acute Chest Syndrome: a Single-Center Experience.
    Hemoglobin. 2020;44:71-77.
    PubMed     Abstract available

  21. CHEN YJ, Li YQ, Liu Q, Tang LY, et al
    A Chinese Male with Normal Hematological Indices and High Hb A2 Levels in beta-Thalassemia Trait.
    Hemoglobin. 2020;44:131-133.
    PubMed     Abstract available

    January 2020
  22. SEMKIU KM, Oliveira JL, Nguyen PL, Porter TR, et al
    Hb F-Wentzville [(G)gamma24(B6)Gly-->Glu; HBG2: c.74G>A, p.Gly25Glu]: An Unstable (G)gamma-Globin Variant Associated with Neonatal Hemolytic Anemia.
    Hemoglobin. 2020 Jan 27:1-3. doi: 10.1080/03630269.2020.1716002.
    PubMed     Abstract available

  23. SARIHI R, Amirizadeh N, Oodi A, Azarkeivan A, et al
    Distribution of Red Blood Cell Alloantibodies Among Transfusion-Dependent beta-Thalassemia Patients in Different Population of Iran: Effect of Ethnicity.
    Hemoglobin. 2020;44:31-36.
    PubMed     Abstract available

  24. BELISARIO AR, Carneiro-Proietti AB, Sabino EC, Araujo A, et al
    Hb S/beta-Thalassemia in the REDS-III Brazil Sickle Cell Disease Cohort: Clinical, Laboratory and Molecular Characteristics.
    Hemoglobin. 2020;44:1-9.
    PubMed     Abstract available

  25. MASHON RS, Das R, Dhawan R, Kakkar N, et al
    Hb Rush (HBB: c.304G>C): A Rare Variant Hemoglobin Mimicking the Hb S (HBB: c.20A>T) Variant on High Performance Liquid Chromatography.
    Hemoglobin. 2020;44:64-66.
    PubMed     Abstract available

  26. MIR SA, Alshehri BM, Alaidarous M, Banawas SS, et al
    Prevalence of Hemoglobinopathies (beta-Thalassemia and Sickle Cell Trait) in the Adult Population of Al Majma'ah, Saudi Arabia.
    Hemoglobin. 2020;44:47-50.
    PubMed     Abstract available

  27. NAZ S, Rehman SU, Shakeel M, Rehman H, et al
    Molecular Heterogeneity of beta-Thalassemia in the Kohat Region, Khyber Pakhtunkhwa Province, Pakistan.
    Hemoglobin. 2020;44:37-41.
    PubMed     Abstract available

  28. AL-RIYAMI AZ, Daar S, Kindi SA, Madhani AA, et al
    alpha-Globin Genotypes Associated with Hb H Disease: A Report from Oman and a Review of the Literature from the Eastern Mediterranean Region.
    Hemoglobin. 2020;44:20-26.
    PubMed     Abstract available

  29. ROPERO P, Arbeteta J, Nieto JM, Gonzalez FA, et al
    Nondeletional alpha-Thalassemia: Two New Mutations on the alpha2 Gene.
    Hemoglobin. 2020;44:17-19.
    PubMed     Abstract available

  30. VAN GAMMEREN AJ, Pelkmans L, Endschot CCWV, Roelofsen-de Beer RJAC, et al
    An Unusual Compound Heterozygosity for Hb O-Arab (HBB: c.364G>A) and Hb D-Los Angeles (HBB: c.364G>C).
    Hemoglobin. 2020;44:61-63.
    PubMed     Abstract available

  31. LUO H, Zou Y, Liu Y
    A Novel beta-Thalassemia Mutation [IVS-I-6 (T>G), HBB: c.92+6T>G] in a Chinese Family.
    Hemoglobin. 2020;44:55-57.
    PubMed     Abstract available

  32. CHEN X, Luo S, Huang J, Yuan D, et al
    Diagnosis and Prenatal Diagnosis in a Chinese Family Carrying the Rare alpha-Thalassemia Gene HBA2: c.1A>G Mutation.
    Hemoglobin. 2020;44:51-54.
    PubMed     Abstract available

  33. SAKAMOTO A, Nakadate H, Tada K, Yamashiro Y, et al
    A Japanese Family with the Unstable Hb Sydney (HBB: c.203T>C) Variant and Persistent Low Hemoglobin Oxygen Saturation.
    Hemoglobin. 2020;44:58-60.
    PubMed     Abstract available

  34. SHOUJAA A, Moasses F, Mukhalalaty Y, Murad H, et al
    Genotype/Phenotype Correlation of beta-Thalassemia in Syrian Patients: A Cross-Sectional Study.
    Hemoglobin. 2020;44:42-46.
    PubMed     Abstract available

  35. SAJADPOUR Z, Amini-Farsani Z, Motovali-Bashi M, Yadollahi M, et al
    Association between Different Polymorphic Markers and beta-Thalassemia Intermedia in Central Iran.
    Hemoglobin. 2020;44:27-30.
    PubMed     Abstract available

    December 2019
  36. MAKIS A, Georgiou I, Traeger-Synodinos J, Storino MR, et al
    A Novel epsilongammadeltabeta-Thalassemia Deletion Associated with Severe Anemia at Birth and a beta-Thalassemia Intermedia Phenotype Later in Life in Three Generations of a Greek Family.
    Hemoglobin. 2019 Dec 12:1-4. doi: 10.1080/03630269.2019.1699568.
    PubMed     Abstract available

    October 2019
  37. JIANG H, Jiang F, Li J, Tang F, et al
    Congenital Nonspherocytic Hemolytic Anemia Caused by Kruppel-Like Factor 1 Gene Variants: Another Case Report.
    Hemoglobin. 2019 Oct 23:1-4. doi: 10.1080/03630269.2019.1680384.
    PubMed     Abstract available

    August 2019
  38. KUNO S, Penglong T, Srinoun K
    Anemia Severity in beta-Thalassemia Correlates with Elevated Levels of microRNA-125b in Activated Phagocytic Monocytes.
    Hemoglobin. 2019 Aug 4:1-7. doi: 10.1080/03630269.2019.1628043.
    PubMed     Abstract available

    June 2019
  39. BIENZ MN, Hsia C, Waye JS, Bode M, et al
    A Novel Human beta-Globin Gene Variant [Hb London-Ontario, HBB: c.332T>G] is Associated with Transfusion-Dependent Anemia in a Patient with a Hemoglobin Electrophoresis Pattern Consistent with beta-Thalassemia Trait.
    Hemoglobin. 2019 Jun 27:1-3. doi: 10.1080/03630269.2019.1619575.
    PubMed     Abstract available

  40. KLEI TRL, Kheradmand Kia S, Veldthuis M, Dehbozorgian J, et al
    A Homozygous Mutation on the HBA1 Gene Coding for Hb Charlieu (HBA1: c.320T>C) Together with beta-Thalassemia Trait Results in Severe Hemolytic Anemia.
    Hemoglobin. 2019 Jun 13:1-6. doi: 10.1080/03630269.2019.1601107.
    PubMed     Abstract available

    May 2019
  41. GRIMHOLT RM, Fjeld B, Selsas H, Schwettmann L, et al
    Hb Aalesund (HBA2: c.400_406delAGCACCG), an Unstable alpha-Globin Variant Found in a Norwegian Patient Causing Moderate Hemolytic Anemia and Falsely High Hb A1c Using Ion Exchange High Performance Liquid Chromatography.
    Hemoglobin. 2019 May 30:1-4. doi: 10.1080/03630269.2019.1614048.
    PubMed     Abstract available

  42. ADEYEMO TA, Diaku-Akinwunmi IN, Ojewunmi OO, Bolarinwa AB, et al
    Barriers to the use of hydroxyurea in the management of sickle cell disease in Nigeria.
    Hemoglobin. 2019;43:188-192.
    PubMed     Abstract available

  43. CANNATA M, Cassara F, Vinciguerra M, Licari P, et al
    Double Heterozygosity for Hb Durham-N.C. (HBB: c.344T>C) [beta114(G16)Leu-->Pro] and the IVS-I-110 (HBB: c.93-21G>A) Causing a Severe beta-Thalassemia Phenotype.
    Hemoglobin. 2019;43:210-213.
    PubMed     Abstract available

  44. SAFAEI S, Abedi H, Parand S, Karimi M, et al
    Evaluation of the Effect of Support-Training System of Peer Group on Promotion of Self-Care in beta-Thalassemia Major Patients in Southern Iran.
    Hemoglobin. 2019;43:198-203.
    PubMed     Abstract available

  45. WANG MK, Shergill R, Jefkins M, Cheung J, et al
    A sickle cell disease patient with dural venous sinus thrombosis: a case report and literature review.
    Hemoglobin. 2019;43:193-197.
    PubMed     Abstract available

  46. YILMAZ S
    The Spectrum of beta-Thalassemia Mutations in Siirt Province, Southeastern Turkey.
    Hemoglobin. 2019;43:174-181.
    PubMed     Abstract available

  47. BORGES E, Tchonhi C, Couto CSB, Gomes V, et al
    Unusual beta-Globin Haplotype Distribution in Newborns from Bengo, Angola.
    Hemoglobin. 2019;43:149-154.
    PubMed     Abstract available

  48. YASSOUF MY, Alquobaili F, Kabalan Y, Mukhalalaty Y, et al
    Compliance with Deferoxamine Therapy and Thyroid Dysfunction of Patients with beta-Thalassemia Major in Syria.
    Hemoglobin. 2019;43:218-221.
    PubMed     Abstract available

  49. HASAN KN, Sufian A, Mazumder AK, Khaleque MA, et al
    A Novel Pathogenic beta-Thalassemia Mutation Identified at Codon 8 (HBB: c.27delG) in a Bangladeshi Family Acquired De Novo.
    Hemoglobin. 2019;43:162-165.
    PubMed     Abstract available

  50. ABDULLAH UYH, Ibrahim HM, Mahmud NB, Salleh MZ, et al
    Quadrupole-Time-of-Flight Mass Spectrometric Identification of Hemoglobin Subunits alpha, beta, gamma and delta in Unknown Peaks of High Performance Liquid Chromatography of Hemoglobin in beta-Thalassemias.
    Hemoglobin. 2019;43:182-187.
    PubMed     Abstract available

  51. HADIPOUR DEHSHAL M, Tabrizi Namini M, Hantoushzadeh R, Yousefi Darestani S, et al
    beta-Thalassemia in Iran: Things Everyone Needs to Know About This Disease.
    Hemoglobin. 2019;43:166-173.
    PubMed     Abstract available

    March 2019
  52. MORADI K, Aznab M, Tahmasebi S, Dastafkan Z, et al
    The Spectrum of alpha-Thalassemia Mutations in the Lak Population of Iran.
    Hemoglobin. 2019;43:107-111.
    PubMed     Abstract available

  53. JIT BP, Mohanty PK, Pradhan A, Purohit P, et al
    Erythrocyte cAMP in Determining Frequency of Acute Pain Episodes in Sickle Cell Disease Patients from Odisha State, India.
    Hemoglobin. 2019;43:88-94.
    PubMed     Abstract available

  54. ZHOU JY, Jiang F, Li J, Chen GL, et al
    Coinheritance of Hb City of Hope (HBB: c.208G>A) and beta-Thalassemia: Compromising the Molecular Diagnosis of the Codons 71/72 (+A) (HBB: c.216_217insA) Mutation by Reverse Dot-Blot Hybridization.
    Hemoglobin. 2019;43:145-147.
    PubMed     Abstract available

  55. HEIREMAN L, Luyckx A, Schynkel K, Dheedene A, et al
    Detection of a Large Novel alpha-Thalassemia Deletion in an Autochthonous Belgian Family.
    Hemoglobin. 2019;43:112-115.
    PubMed     Abstract available

  56. YANG K, Ren Q, Wu Y, Zhou Y, et al
    A Case of Hereditary Spherocytosis Caused by a Novel Homozygous Mutation in the SPTB Gene Misdiagnosed as beta-Thalassemia Intermedia Due to a KLF1 Gene Mutation.
    Hemoglobin. 2019;43:140-144.
    PubMed     Abstract available

  57. NGIM CF, Lee MY, Othman N, Lim SM, et al
    Prevalence and Risk Factors for Cardiac and Liver Iron Overload in Adults with Thalassemia in Malaysia.
    Hemoglobin. 2019;43:95-100.
    PubMed     Abstract available

  58. ADEKILE AD, Al-Sherida S, Marouf R, Mustafa N, et al
    The Sub-Phenotypes of Sickle Cell Disease in Kuwait.
    Hemoglobin. 2019;43:83-87.
    PubMed     Abstract available

  59. SUN M, Lou J, Zhag Y, Fu Y, et al
    Polymorphisms of alpha-Globin Genes Compromise Polymerase Chain Reaction-Based alpha-Thalassemia Genotyping in Three Chinese Families.
    Hemoglobin. 2019;43:101-106.
    PubMed     Abstract available

  60. XIE XM, Liu YN, Li J, Jiang F, et al
    A Kruppel-Like Factor 1 Gene Mutation Ameliorates the Severity of beta-Thalassemia: A Case Report.
    Hemoglobin. 2019;43:137-139.
    PubMed     Abstract available

    January 2019
  61. AZIMI A, Nejati P, Tahmasebi S, Alimoradi S, et al
    Characterization of the IVS-II-821 (A>C) (HBB: c.316-30A>C) Mutation in a beta-Thalassemia Phenotype in Iran.
    Hemoglobin. 2019;43:23-26.
    PubMed     Abstract available

  62. NUINOON M, Thipthara O, Fucharoen S
    Compound Heterozygote for a Novel Elongated C-Terminal beta-Globin Variant (HBB: c.364delG) and Hb E (HBB: c.79G>A) with Heterozygous alpha-Thalassemia-2.
    Hemoglobin. 2019;43:52-55.
    PubMed     Abstract available

  63. JIANG F, Li J, Zhou JY, Liao C, et al
    Regulatory Single Nucleotide Polymorphism rs368698783 (G>A): a Genetic Modifier of Hb F Production Only under Erythropoietic Stress Characteristic for beta-Globin Chain Deficiency?
    Hemoglobin. 2019;43:73-75.
    PubMed     Abstract available

  64. ALIBAKHSHI R, Moradi K, Aznab M, Azimi A, et al
    The Spectrum of beta-Thalassemia Mutations in Hamadan Province, West Iran.
    Hemoglobin. 2019;43:18-22.
    PubMed     Abstract available

  65. CURCIO C, Giannone V, Benzoni E, Cesaretti C, et al
    Hb Milano [alpha109(G16)Leu-->Pro (CTG>CCG); HBA1: c.329T>C]: A Novel Variant on the alpha1-Globin Gene in an Italian Family.
    Hemoglobin. 2019;43:4-6.
    PubMed     Abstract available

  66. SU Q, Chen S, Wu L, Tian R, et al
    Severe Thalassemia Caused by Hb Zunyi [beta147(HC3)Stop-->Gln; HBB: c.442T>C)] on the beta-Globin Gene.
    Hemoglobin. 2019;43:7-11.
    PubMed     Abstract available

  67. PARSAEE M, Pouraliakbar H, Azarkeivan A, Ghadrdoost B, et al
    The Role of Exercise Stress Echocardiography for Determination of Subclinical Cardiac Involvement in beta-Thalassemia Major.
    Hemoglobin. 2019;43:34-37.
    PubMed     Abstract available

  68. AGBUDUWE C, Rugless M, Asba N, Proven M, et al
    Severe Drug-Induced Hemolysis in a Patient with Compound Heterozygosity for Hb Peterborough (HBB: c.334G>T) and Hb Lepore-Boston-Washington (NG_000007.3: g.63632_71046del).
    Hemoglobin. 2019;43:56-59.
    PubMed     Abstract available

  69. KOLLIOPOULOU A, Siamoglou S, John A, Sgourou A, et al
    Role of Genomic Biomarkers in Increasing Fetal Hemoglobin Levels Upon Hydroxyurea Therapy and in beta-Thalassemia Intermedia: A Validation Cohort Study.
    Hemoglobin. 2019;43:27-33.
    PubMed     Abstract available

  70. INTASAI N, Phasit A, Panyasai S, Pornprasert S, et al
    A Case Report of Compound Heterozygosity for beta(0)/beta(+)-Thalassemia Resulting from under Diagnosed beta-Thalassemia Found in a Hb A'2 Sample.
    Hemoglobin. 2019;43:63-65.
    PubMed     Abstract available

  71. YAO X, Xu LH, Xu HG, Li XY, et al
    Iron Metabolism and Oxidative Status in Patients with Hb H Disease.
    Hemoglobin. 2019;43:38-41.
    PubMed     Abstract available

  72. BHAT A, Neculiseanu E, Tam EL, Gendy A, et al
    Purulent Pericarditis in Sickle Cell Disease Due to Streptococcus agalactiae; a Unique Case Report and Literature Review.
    Hemoglobin. 2019;43:1-3.
    PubMed     Abstract available

  73. MURAD H, Moassas F
    First Report on the Coinheritance of alpha-Thalassemia and a Rare beta-Thalassemia Compound Heterozygosity for the IVS-I-I(G>A)/IVS-II-705(T>G) Mutations in a Syrian Family.
    Hemoglobin. 2019;43:66-68.
    PubMed     Abstract available

  74. ZHAO Y, Lou J, Sun M, Fu Y, et al
    Hb H Disease Results from Compound Heterozygosity of - -(SEA) and -alpha(MAL3.5) in a Chinese Family.
    Hemoglobin. 2019;43:69-72.
    PubMed     Abstract available

  75. TAMADDONI A, Khabaz Astaneh S, Tabaripour R, Akhavan-Niaki H, et al
    Kruppel-Like Factor 1 Gene Mutations in Thalassemia Patients from North Iran: Report of a New Mutation Associated with beta-Thalassemia Intermedia.
    Hemoglobin. 2019;43:12-17.
    PubMed     Abstract available

    October 2018
  76. PU J, Zhang L, Wei X, Xu X, et al
    Clinical Genotyping by Next Generation Sequencing Reveals a Novel, De Novo beta-Globin Gene Mutation Causing Hemolytic Anemia in a Chinese Individual.
    Hemoglobin. 2018 Oct 2:1-5. doi: 10.1080/03630269.2018.1496928.
    PubMed     Abstract available

    July 2018
  77. ALAUDDIN H, Kamarudin K, Loong TY, Azma RZ, et al
    A Unique Interaction of IVS-I-1 (G>A) (HBA2: c.95+1G>A) with Hb Adana (HBA2: c.179G>A) Presenting as Transfusion-Dependent alpha-Thalassemia.
    Hemoglobin. 2018;42:247-251.
    PubMed     Abstract available

  78. SARGOLZAIE N, Montazer Zohour M, Ayubi E, Shahraki F, et al
    Relationship Between Social Determinants of Health and the Thalassemia Prenatal Diagnosis Test in Zahedan, South Eastern Iran.
    Hemoglobin. 2018;42:231-235.
    PubMed     Abstract available

  79. DASH PM, Sahu PK, Patel S, Mashon RS, et al
    Effect of Assorted Globin Haplotypes and alpha-Thalassemia on the Clinical Heterogeneity of Hb S-beta-Thalassemia.
    Hemoglobin. 2018;42:236-242.
    PubMed     Abstract available

    May 2018
  80. XU C, Liao B, Qi Y, Huangfu Z, et al
    Analysis of Gene Mutation Types of alpha- and beta-Thalassemia in Fuzhou, Fujian Province in China.
    Hemoglobin. 2018;42:143-147.
    PubMed     Abstract available

  81. BARBERO U, Fornari F, Guarguagli S, Gaglioti CM, et al
    Atrial fibrillation in beta-thalassemia Major Patients: Diagnosis, Management and Therapeutic Options.
    Hemoglobin. 2018;42:189-193.
    PubMed     Abstract available

  82. CHEN JK, Xin XQ, Huang JG
    A Novel beta-Thalassemia Mutation in a Chinese family: IVS-II-203-205 (TCT>CC) (HBB: c.315+203TCT>CC).
    Hemoglobin. 2018;42:159-160.
    PubMed     Abstract available

  83. JIANG F, Qu YX, Chen GL, Li J, et al
    KFL1 Gene Variants in alpha-Thalassemia Individuals with Increased Fetal Hemoglobin in a Chinese Population.
    Hemoglobin. 2018;42:161-165.
    PubMed     Abstract available

  84. CHOMEAN S, Pholyiam K, Thamwarokun A, Kaset C, et al
    Development of Visual Detection of alpha-Thalassemia-1 (the - -(SEA) Deletion) Using pH-Sensitive Loop-Mediated Isothermal Amplification.
    Hemoglobin. 2018;42:171-177.
    PubMed     Abstract available

  85. MOASSAS F, Alabloog A, Murad H
    Description of a Rare beta-Globin Gene Mutation: -86 (C>G) (HBB: c.-136C>G) Observed in a Syrian Family.
    Hemoglobin. 2018;42:203-205.
    PubMed     Abstract available

    April 2018
  86. GODBOLE KG, Ramachandran A, Karkamkar AS, Dalal AB, et al
    Compound Heterozygosity for Hb Alperton (HBB: c.407C>T) and IVS-I-5 (G>C) (HBB: c.92+5G>C) Mutations Presenting as a Moderate Anemia in an Indian Family.
    Hemoglobin. 2018 Apr 13:1-2. doi: 10.1080/03630269.2018.1450754.
    PubMed     Abstract available

    March 2018
  87. MELLA F, Yamashiro Y, Adhiyanto C, Tanaka T, et al
    A Coincidental Discovery of a New Stable Variant (Hb Hachioji or HBB: c.187C>T) in a Patient with Chronic Hemolytic Anemia of Unexplained Origin.
    Hemoglobin. 2018 Mar 7:1-6. doi: 10.1080/03630269.2018.1429279.
    PubMed     Abstract available

  88. JHA AN, Mishra H, Verma HK, Pandey I, et al
    Compound Heterozygosity of beta-Thalassemia and the Sickle Cell Hemoglobin in Various Populations of Chhattisgarh State, India.
    Hemoglobin. 2018;42:84-90.
    PubMed     Abstract available

  89. KHAN NM, Rehman SU, Shakeel M, Khan S, et al
    Molecular Characterization of beta-Thalassemia Mutations Via the Amplification Refractory Mutation System-Polymerase Chain Reaction Method at the North Waziristan Agency, Pakistan.
    Hemoglobin. 2018;42:91-95.
    PubMed     Abstract available

  90. BELHAJ NEFISSI R, Doggui R, Ouali F, Messaoud T, et al
    Factor V Leiden G1691A, Prothrombin G20210A, and MTHFR C677T and A1298C Mutations in Patients With Sickle Cell Disease in Tunisia.
    Hemoglobin. 2018;42:96-102.
    PubMed     Abstract available

  91. LISTI F, Sclafani S, Agrigento V, Barone R, et al
    Study on the Role of Polymorphisms of the SOX-6 and MYB Genes and Fetal Hemoglobin Levels in Sicilian Patients with beta-Thalassemia and Sickle Cell Disease.
    Hemoglobin. 2018;42:103-107.
    PubMed     Abstract available

  92. BAYHAN T, Unal S, Konuskan B, Erdem O, et al
    Assessment of Peripheral Neuropathy in Patients with beta-Thalassemia via Electrophysiological Study: Reevaluation in the Era of Iron Chelators.
    Hemoglobin. 2018;42:113-116.
    PubMed     Abstract available

  93. VAN DE WATER N, Tan T, Crowley M, Kerr R, et al
    Novel alpha-Globin Splice Site Mutation (HBA2: c.96-5C>A) in Combination with Three-Gene Deletion Hb H Disease.
    Hemoglobin. 2018;42:122-125.
    PubMed     Abstract available

  94. GRIMHOLT RM, Harteveld CL, Arkesteijn SGJ, Fjeld B, et al
    Characterization of Two Deep Intronic Variants on the beta-Globin Gene with Inconsistent Interpretations of Clinical Significance.
    Hemoglobin. 2018;42:126-128.
    PubMed     Abstract available

  95. GRIMHOLT RM, Vestli A, Urdal P, Bechensteen AG, et al
    Hb Oslo [beta42(CD1)Phe-->Ile; HBB: c.127T>A]: A Novel Unstable Hemoglobin Variant Found in a Norwegian Patient.
    Hemoglobin. 2018;42:78-83.
    PubMed     Abstract available

  96. ZHAO P, Weng R, Wu H
    Molecular Spectrum of alpha- and beta-Thalassemia Mutations in a Large Ethnic Hakka Population in Southern China.
    Hemoglobin. 2018;42:117-121.
    PubMed     Abstract available

  97. THEODORIDOU S, Teli A, Yfanti E, Vyzantiadis TA, et al
    Compound Heterozygosity for Hb Adana (HBA2: c.179G>A) and the -alpha(3.7)/alphaalpha Thalassemia Deletion in Greece: Clinical Phenotype and Genetic Counseling.
    Hemoglobin. 2018;42:129-131.
    PubMed     Abstract available

  98. ARDUINI GAO, Trovo de Marqui AB
    Prevalence and Characteristics of Priapism in Sickle Cell Disease.
    Hemoglobin. 2018;42:73-77.
    PubMed     Abstract available

  99. NICKARIA S, Haghpanah S, Ramzi M, Karimi M, et al
    Relationship of the Interaction Between Two Quantitative Trait Loci with gamma-Globin Expression in beta-Thalassemia Intermedia Patients.
    Hemoglobin. 2018;42:108-112.
    PubMed     Abstract available

  100. DANA M, Fibach E
    Fetal Hemoglobin in the Maternal Circulation - Contribution of Fetal Red Blood Cells.
    Hemoglobin. 2018;42:138-140.
    PubMed     Abstract available

  101. TANG HS, Wang DG, Huang LY, Li DZ, et al
    delta-Thalassemia with Complete Absence of Hb A2 in a Chinese Family.
    Hemoglobin. 2018;42:135-137.
    PubMed     Abstract available

  102. SUN M, Lou J, Zhao Y, Liu Y, et al
    Molecular and Hematological Characterization of Two Novel delta-Globin Gene Mutations Found in Chinese Individuals.
    Hemoglobin. 2018;42:132-134.
    PubMed     Abstract available

    January 2018
  103. SEWARALTHAHAB SS, Menaker J, Law JY
    Successful Use of Veno-Venous Extracorporeal Membrane Oxygenation in an Adult Patient with Sickle Cell Anemia and Severe Acute Chest Syndrome.
    Hemoglobin. 2018;42:65-67.
    PubMed     Abstract available

  104. MANCUSO L, Vitrano A, Mancuso A, Sacco M, et al
    Left Ventricular Diastolic Dysfunction in beta-Thalassemia Major with Heart Failure.
    Hemoglobin. 2018;42:68-71.
    PubMed     Abstract available

  105. GHABER SM, Trabelsi N, Salem ML, Haddad F, et al
    Hb Moscva [beta24(B6)Gly-->Asp (GGT>GAT), HBB: c.74G>A]: An Unstable Hemoglobin Newly Detected as a De Novo Mutation in a Mauritanian Patient.
    Hemoglobin. 2018;42:7-10.
    PubMed     Abstract available

  106. VOSPER J, Evangeli M, Porter JB, Shah F, et al
    Psychological Factors Associated with Episodic Chelation Adherence in Thalassemia.
    Hemoglobin. 2018;42:30-36.
    PubMed     Abstract available

  107. HE S, Li J, Huang P, Zhang S, et al
    Characterization of Hb Bart's Hydrops Fetalis Caused by - -(SEA) and a Large Novel alpha(0)-Thalassemia Deletion.
    Hemoglobin. 2018;42:61-64.
    PubMed     Abstract available

  108. VO LTT, Nguyen TT, Le HX, Le HTT, et al
    Analysis of Common beta-Thalassemia Mutations in North Vietnam.
    Hemoglobin. 2018;42:16-22.
    PubMed     Abstract available

  109. MOUKHADDER HM, Roumi JE, Bou-Fakhredin R, Taher AT, et al
    Hepatocellular Carcinoma in a beta-Thalassemia Intermedia Patient: Yet Another Case in the Expanding Epidemic.
    Hemoglobin. 2018;42:58-60.
    PubMed     Abstract available

  110. PANG W, Long J, Weng X, Fan Q, et al
    Identification of Three Types of alpha-Thalassemia Deletion, -alpha(21.9), -alpha(2.4), and - -(THAI), and Their Frequencies, in One Family in the Population of Southern Guangxi Zhuang Autonomous Region, People's Republic of China.
    Hemoglobin. 2018;42:37-42.
    PubMed     Abstract available

  111. UPADHYE D, Das RS, Ray J, Acharjee S, et al
    Newborn Screening for Hemoglobinopathies and Red Cell Enzymopathies in Tripura State: A Malaria-Endemic State in Northeast India.
    Hemoglobin. 2018;42:43-46.
    PubMed     Abstract available

    November 2017
  112. RIZK S, Pulte ED, Axelrod D, Ballas SK, et al
    Perinatal Maternal Mortality in Sickle Cell Anemia: Two Case Reports and Review of the Literature.
    Hemoglobin. 2017 Nov 28:1-5. doi: 10.1080/03630269.2017.1397017.
    PubMed     Abstract available

    July 2017
  113. KANDHRO AH, Prachayasittikul V, Isarankura Na-Ayudhya C, Nuchnoi P, et al
    Prevalence of Thalassemia Traits and Iron Deficiency Anemia in Sindh, Pakistan.
    Hemoglobin. 2017 Jul 26:1-7. doi: 10.1080/03630269.2017.1345759.
    PubMed     Abstract available

  114. PEDROSO GA, Kimura EM, Santos MNN, Albuquerque DM, et al
    Coinheritance of Hb Bristol-Alesha [beta67(E11)Val-->Met; HBB: c.202G>A] and the alpha212 Patchwork Allele in a Brazilian Child with Severe Congenital Hemolytic Anemia.
    Hemoglobin. 2017 Jul 3:1-6. doi: 10.1080/03630269.2017.1340305.
    PubMed     Abstract available

    June 2017
  115. PORNPRASERT S, Thongsat C, Panyachadporn U
    Evaluation of Applying a Combination of Red Cell Indexes and Formulas to Differentiate beta-Thalassemia Trait from Iron Deficiency Anemia in the Thai Population.
    Hemoglobin. 2017 Jun 9:1-4. doi: 10.1080/03630269.2017.1323763.
    PubMed     Abstract available

    April 2017
  116. WAH ST, Yi YS, Khin AA, Plabplueng C, et al
    Prevalence of Anemia and Hemoglobin Disorders Among School Children in Myanmar.
    Hemoglobin. 2017 Apr 2:1-6. doi: 10.1080/03630269.2017.1289103.
    PubMed     Abstract available

    March 2017
  117. D'AMBROSIO R, Maggioni M, Donato MF, Lampertico P, et al
    Decompensated Cirrhosis and Sickle Cell Disease: Case Reports and Review of the Literature.
    Hemoglobin. 2017;41:131-133.
    PubMed     Abstract available

  118. HOJJATI MT, Azarkeivan A, Pourfathollah AA, Amirizadeh N, et al
    Comparison of MicroRNAs Mediated in Reactivation of the gamma-Globin in beta-Thalassemia Patients, Responders and Non-Responders to Hydroxyurea.
    Hemoglobin. 2017;41:110-115.
    PubMed     Abstract available

  119. DORO MG, Casu G, Frogheri L, Persico I, et al
    Molecular Characterization of beta-Thalassemia Mutations in Central Vietnam.
    Hemoglobin. 2017;41:96-99.
    PubMed     Abstract available

  120. GUEYE TALL F, Martin C, Malick Ndour EH, Deme Ly I, et al
    Genetic Background of the Sickle Cell Disease Pediatric Population of Dakar, Senegal, and Characterization of a Novel Frameshift beta-Thalassemia Mutation [HBB: c.265_266del; p.Leu89Glufs*2].
    Hemoglobin. 2017;41:89-95.
    PubMed     Abstract available

  121. GHOTI H, Fibach E, Rachmilewitz EA, Jeadi H, et al
    New Insights on beta-Thalassemia in the Palestinian Population of Gaza: High Frequency and Milder Phenotype Among Homozygous IVS-I-1 (HBB: c.92+1G>A) Patients with High Levels of Hb F.
    Hemoglobin. 2017;41:144-146.
    PubMed     Abstract available

  122. HUSSAIN A, Ahmed S, Ali N, S Mailk H, et al
    Rare beta-Globin Gene Mutations in Pakistan.
    Hemoglobin. 2017;41:100-103.
    PubMed     Abstract available

  123. MUHAMMAD R, Shakeel M, Rehman SU, Lodhi MA, et al
    Population-Based Genetic Study of beta-Thalassemia Mutations in Mardan Division, Khyber Pakhtunkhwa Province, Pakistan.
    Hemoglobin. 2017;41:104-109.
    PubMed     Abstract available

  124. BUCAK IH, Almis H, Benli S, Turgut M, et al
    The Assessment of Skin Color and Iron Levels in Pediatric Patients with beta-Thalassemia Major Using a Visual Skin Color Chart.
    Hemoglobin. 2017;41:120-123.
    PubMed     Abstract available

  125. NWEGBU MM, Isa HA, Nwankwo BB, Okeke CC, et al
    Preliminary Evaluation of a Point-of-Care Testing Device (SickleSCAN) in Screening for Sickle Cell Disease.
    Hemoglobin. 2017;41:77-82.
    PubMed     Abstract available

  126. BASHA B, Mularo F, Cook JR
    Design, Validation, and Clinical Implementation of a Gap-Polymerase Chain Reaction Method for alpha-Thalassemia Genotyping Using Capillary Electrophoresis.
    Hemoglobin. 2017;41:124-130.
    PubMed     Abstract available

  127. HADDAD F, Trabelsi N, Chaouch L, Darragi I, et al
    Homozygous Mutation on the beta-Globin Polyadenylation Signal in a Tunisian Patient with beta-Thalassemia Intermedia and Coinheritance of Gilbert's Syndrome.
    Hemoglobin. 2017;41:147-150.
    PubMed     Abstract available

  128. LIU J, Huang Y, Lei Y, Lai Y, et al
    Hb Southampton [beta106(G8)Leu-->Pro; HBB: c.320T>C] and Codons 41/42 (-TTCT; HBB: c.124_127delTTCT) in a Chinese Girl.
    Hemoglobin. 2017;41:134-136.
    PubMed     Abstract available

    January 2017
  129. AZIMI A, Alibakhshi R, Hayati H, Tahmasebi S, et al
    IVS-II-648/649 (-T) (HBB: c.316-202del) Triggers a Novel beta-Thalassemia Phenotype.
    Hemoglobin. 2017;41:44-46.
    PubMed     Abstract available

  130. HE S, Qin Q, Lin L, Chen Q, et al
    Complex Interaction of Hb Q-Thailand with alpha0- and beta0-Thalassemia in a Chinese Family.
    Hemoglobin. 2017;41:68-72.
    PubMed     Abstract available

  131. JIANG F, Huang LY, Chen GL, Zhou JY, et al
    A Novel Frameshift Mutation at Codons 138/139 (HBB: c.417_418insT) on the beta-Globin Gene Leads to beta-Thalassemia.
    Hemoglobin. 2017;41:59-60.
    PubMed     Abstract available

  132. ADAM S, Afifi H, Thomas M, Magdy P, et al
    Quality of Life Outcomes in a Pediatric Thalassemia Population in Egypt.
    Hemoglobin. 2017;41:16-20.
    PubMed     Abstract available

  133. LECKNGAM P, Limweeraprajak E, Kiewkarnkha T, Tatu T, et al
    The Hb E (HBB: c.79G>A), Mean Corpuscular Volume, Mean Corpuscular Hemoglobin Cutoff Points in Double Heterozygous Hb E/- -SEA alpha-Thalassemia-1 Carriers are Dependent on Hemoglobin Levels.
    Hemoglobin. 2017;41:38-43.
    PubMed     Abstract available

  134. CHEN B, Lin L, Yi S, Chen Q, et al
    A Novel Mutation of the alpha2-Globin Gene Causing alpha+-Thalassemia: Hb Nanning (HBA2: c.369_370delinsGA).
    Hemoglobin. 2017;41:56-58.
    PubMed     Abstract available

  135. JALILIAN M, Azizi Jalilian F, Ahmadi L, Amini R, et al
    The Frequency of HBB Mutations Among beta-Thalassemia Patients in Hamadan Province, Iran.
    Hemoglobin. 2017;41:61-64.
    PubMed     Abstract available

  136. CAPPABIANCA MP, Colosimo A, Sabatucci A, Dainese E, et al
    A Clinical Update of the Hb Siirt [beta27(B9)Ala-->Gly; HBB: c.83C>G] Hemoglobin Variant.
    Hemoglobin. 2017;41:53-55.
    PubMed     Abstract available

  137. EFTEKHARI H, Tamaddoni A, Mahmoudi Nesheli H, Vakili M, et al
    A Comprehensive Molecular Investigation of alpha-Thalassemia in an Iranian Cohort from Different Provinces of North Iran.
    Hemoglobin. 2017;41:32-37.
    PubMed     Abstract available

  138. YAVROPOULOU MP, Pikilidou M, Pantelidou D, Tsalikakis DG, et al
    Insulin Secretion and Resistance in Normoglycemic Patients with Sickle Cell Disease.
    Hemoglobin. 2017;41:6-11.
    PubMed     Abstract available

  139. LIN L, Chen B, Yi S, Chen Q, et al
    A Novel alpha2-Globin Gene Mutation: Hb Debao [alpha31(B12)Arg-->Trp; HBA2: c.94A>T].
    Hemoglobin. 2017;41:65-67.
    PubMed     Abstract available

  140. CARROCINI GCS, Venancio LPR, Pessoa VLR, Lobo CLC, et al
    Mutational Profile of Homozygous beta-Thalassemia in Rio de Janeiro, Brazil.
    Hemoglobin. 2017;41:12-15.
    PubMed     Abstract available

  141. LI Y, Yan JM, Zhou JY, Lu YC, et al
    Combination of Hb Heze [beta144(HC1)Lys-->Arg; HBB: c.434A>G] and beta0-Thalassemia in a Chinese Patient with beta-Thalassemia Intermedia.
    Hemoglobin. 2017;41:47-49.
    PubMed     Abstract available

    November 2016
  142. MAINOU M, Kotsiafti A, Klonizakis P, Soulountsi V, et al
    A Case of Fatal Agranulocytosis That Developed in a Patient with beta-Thalassemia Major Treated with Deferiprone.
    Hemoglobin. 2016;40:435-437.
    PubMed     Abstract available

  143. GORELLO P, Arcioni F, Palmieri A, Barbanera Y, et al
    The Molecular Spectrum of beta- and alpha-Thalassemia Mutations in Non-Endemic Umbria, Central Italy.
    Hemoglobin. 2016;40:371-376.
    PubMed     Abstract available

  144. LEE HH, Mak AS, Kou KO, Poon CF, et al
    An Unusual Hydrops Fetalis Associated with Compound Heterozygosity for Kruppel-like Factor 1 mutations.
    Hemoglobin. 2016;40:431-434.
    PubMed     Abstract available

  145. GARCIA-MORIN M, Lopez-Sanguos C, Vazquez P, Alvarez T, et al
    Lactate Dehydrogenase: A Marker of the Severity of Vaso-Occlusive Crisis in Children with Sickle Cell Disease Presenting at the Emergency Department.
    Hemoglobin. 2016;40:388-391.
    PubMed     Abstract available

  146. LAI Y, Chen Y, Chen B, Zheng H, et al
    Genetic Variants at BCL11A and HBS1L-MYB loci Influence Hb F Levels in Chinese Zhuang beta-Thalassemia Intermedia Patients.
    Hemoglobin. 2016;40:405-410.
    PubMed     Abstract available

  147. JIANG H, Yan JM, Zhou JY, Li DZ, et al
    Hb Alesha [beta67(E11)Val-->Met (GTG>ATG); HBB: c.202G > A] Found in a Chinese Girl.
    Hemoglobin. 2016;40:420-421.
    PubMed     Abstract available

  148. BHATTACHARYYA KK, Chatterjee T, Mondal UB
    A comprehensive screening program for beta-thalassemia and other hemoglobinopathies in the Hooghly District of West Bengal, India, dealing with 21 137 cases.
    Hemoglobin. 2016;40:396-399.
    PubMed     Abstract available

  149. KURTOGLU A, Karakus V, Erkal O, Kurtoglu E, et al
    beta-Thalassemia gene mutations in Antalya, Turkey: results from a single centre study.
    Hemoglobin. 2016;40:392-395.
    PubMed     Abstract available

  150. MEJRI A, Mansri M, Hadj Fredj S, Ouali F, et al
    First description of the rs45496295 polymorphism of the C/EBPE gene in beta-thalassemia intermedia patients.
    Hemoglobin. 2016;40:411-416.
    PubMed     Abstract available

  151. PULE GD, Ngo Bitoungui VJ, Chetcha Chemegni B, Kengne AP, et al
    Studies of novel variants associated with Hb F in Sardinians and Tanzanians in sickle cell disease patients from Cameroon.
    Hemoglobin. 2016;40:377-380.
    PubMed     Abstract available

  152. ZHAO L, Qing J, Liang Y, Chen Z, et al
    A novel compound heterozygosity in Southern China: IVS-II-5 (G > C) and IVS-II-672 (A > C).
    Hemoglobin. 2016;40:428-430.
    PubMed     Abstract available

  153. CHAN NC, Lau KM, Cheng KC, Chan NP, et al
    A Multi-locus Approach to Characterization of Major Quantitative Trait Loci Influencing Hb F Regulation in Chinese beta-thalassemia Carriers.
    Hemoglobin. 2016;40:400-404.
    PubMed     Abstract available

    September 2016
  154. JORGENSEN DR, Rosano C, Novelli EM
    Can Neuroimaging Markers of Vascular Pathology Explain Cognitive Performance in Adults with Sickle Cell Anemia? A Review of the Literature.
    Hemoglobin. 2016.
    PubMed     Abstract available

  155. GALLAGHER PG, Maksimova Y, Schulz VP, Forget BG, et al
    Mutation in a Highly Conserved COOH-Terminal Residue of Kruppel-Like Factor 1 Associated with Elevated Hb F in a Compound Heterozygous beta-Thalassemia Patient with a Nontransfusion-Dependent Thalassemia Phenotype.
    Hemoglobin. 2016;40:361-364.
    PubMed     Abstract available

  156. WAYE JS, Eng B, Hanna M, Hohenadel BA, et al
    Novel Mutation of the Translation Initiation Codon of the alpha1-Globin Gene (ATG>AAG or HBA1:c.2T>A).
    Hemoglobin. 2016;40:369-370.
    PubMed     Abstract available

  157. LIM YC, Tan KM, Chong SS, Rajendran J, et al
    A Patient with beta-Thalassemia Intermedia Secondary to Homozygosity for a Polyadenylation Signal Mutation (AATAAA > AATAGA) (HBB: C.*112A > G) on the beta-Globin Gene.
    Hemoglobin. 2016;40:359-360.
    PubMed     Abstract available

  158. PANJA A, Chowdhury P, Basu A
    Hb Midnapore [beta53(D4)Ala-->Val; HBB: c.161C>T]: A Novel Hemoglobin Variant with a Structural Abnormality Associated with IVS-I-5 (G>C) (HBB: c.92+5G>C) Found in a Bengali Indian Family.
    Hemoglobin. 2016;40:300-303.
    PubMed     Abstract available

  159. DERAKHSHAN SM, Khaniani MS, Afkhami F, PourFeizi AH, et al
    Molecular Study of Deletional and Nondeletional Mutations on the alpha-Globin Locus in the Azeri Population of Northwestern Iran.
    Hemoglobin. 2016;40:319-322.
    PubMed     Abstract available

  160. LOOVERS HM, Tamminga N, Mulder AB, Tamminga RY, et al
    Clinical Course of Two Children with Unstable Hemoglobins: The Effect of Hydroxyurea Therapy.
    Hemoglobin. 2016;40:341-344.
    PubMed     Abstract available

  161. YANG X, Yan JM, Li J, Xie XM, et al
    Hydrops Fetalis Associated with Compound Heterozygosity for Hb Zurich-Albisrieden (HBA2: C.178G > C) and the Southeast Asian (- -SEA/) Deletion.
    Hemoglobin. 2016;40:353-355.
    PubMed     Abstract available

  162. PULTE D, Lovett PB, Axelrod D, Crawford A, et al
    Comparison of Emergency Department Wait Times in Adults with Sickle Cell Disease Versus Other Painful Etiologies.
    Hemoglobin. 2016;40:330-334.
    PubMed     Abstract available

  163. YERUVA SL, Paul Y, Oneal P, Nouraie M, et al
    Renal Failure in Sickle Cell Disease: Prevalence, Predictors of Disease, Mortality and Effect on Length of Hospital Stay.
    Hemoglobin. 2016;40:295-299.
    PubMed     Abstract available

  164. ITALIA K, Dabke P, Sawant P, Nadkarni A, et al
    Hb E-beta-Thalassemia in Five Indian States.
    Hemoglobin. 2016;40:310-315.
    PubMed     Abstract available

  165. DING ZY, Shen GS, Zhang S, He PY, et al
    Epidemiology of Hemoglobinopathies in the Huzhou Region, Zhejiang Province, Southeast China.
    Hemoglobin. 2016;40:304-309.
    PubMed     Abstract available

  166. WARD R, Taha KM
    Patient Involvement as Experts in the Development and Assessment of a Smartphone App as a Patient Education Tool for the Management of Thalassemia and Iron Overload Syndromes.
    Hemoglobin. 2016;40:323-329.
    PubMed     Abstract available

  167. ZAREI T, Dehbozorgian J, Imanifard J, Setoodegan F, et al
    A Number of Cases in Iran Presenting with Coinheritance of Hemoglobin-H Disease and Beta-Thalassemia Minor.
    Hemoglobin. 2016;40:316-318.
    PubMed     Abstract available

  168. TORRES LS, Okumura JV, Belini-Junior E, Oliveira RG, et al
    Phenotypic Diversity of Sickle Cell Disease in Patients with a Double Heterozygosity for Hb S and Hb D-Punjab.
    Hemoglobin. 2016;40:356-358.
    PubMed     Abstract available

  169. WANG XY, Lin MX, Lin M
    A novel 6.3 kb deletion and the Rare 27.6 kb Deletion Causing alpha+-Thalassemia in two Chinese Patients.
    Hemoglobin. 2016;40:365-368.
    PubMed     Abstract available

  170. ORTS JA, Zuniga A, Bello Y, Fabregat AB, et al
    Hb A1c Determination by Capillary Electrophoresis is an Efficient Method for Detecting beta-Thalassemias and Hemoglobin Variants.
    Hemoglobin. 2016;40:335-340.
    PubMed     Abstract available

    August 2016
  171. DARVISHI KHEZRI H, Emami Zeydi A, Sharifi H, Jalali H, et al
    Is Vitamin C Supplementation in Patients with beta-Thalassemia Major Beneficial or Detrimental?
    Hemoglobin. 2016;40:293-4.
    PubMed     Abstract available

  172. SOLER AM, Schelotto M, de Oliveira Mota N, Dorta Ferreira R, et al
    The -(alpha)(5.2) Deletion Detected in a Uruguayan Family: First Case Report in the Americas.
    Hemoglobin. 2016;40:289-92.
    PubMed     Abstract available

  173. PONGJANTHARASATIEN K, Banyatsuppasin W, Pounsawat S, Jindadamrongwech S, et al
    Occurrence of the - -(SEA), - -(THAI) and - -(FIL) alpha-Thalassemia-1 Carriers from a 7-Year Study at Ramathibodi Hospital, Bangkok, Thailand.
    Hemoglobin. 2016;40:283-4.
    PubMed     Abstract available

  174. HE S, Lin L, Wei Y, Chen B, et al
    Identification of a Novel beta-Globin Mutation (HBB: C.189_195delTCATGGC) in a Chinese Family.
    Hemoglobin. 2016;40:277-9.
    PubMed     Abstract available

  175. YANG Y, Li DZ, He P
    A Program on Noninvasive Prenatal Diagnosis of alpha-Thalassemia in Mainland China: A Cost-Benefit Analysis.
    Hemoglobin. 2016;40:247-9.
    PubMed     Abstract available

  176. BILGEN T, Canatan D, Delibas S, Keser I, et al
    A Novel Mutation in the Promoter Region of the beta-Globin Gene: HBB: c.-127G > C.
    Hemoglobin. 2016;40:280-2.
    PubMed     Abstract available

  177. VINCIGUERRA M, Passarello C, Leto F, Crivello A, et al
    Coinheritance of a Rare Nucleotide Substitution on the beta-Globin Gene and Other Known Mutations in the Globin Clusters: Management in Genetic Counseling.
    Hemoglobin. 2016;40:231-5.
    PubMed     Abstract available

  178. YANG Y, Li DZ, He P
    Hb Dapu (HBA2: c.52G > T): A Novel Nondeletional alpha-Thalassemia Mutation.
    Hemoglobin. 2016;40:264-6.
    PubMed     Abstract available

  179. MEHER S, Dehury S, Mohanty PK, Patel S, et al
    Hb Tianshui (HBB: C.119A > G) in Compound Heterozygosity with Hb S (HBB: C.20A > T) from Odisha, India.
    Hemoglobin. 2016;40:270-2.
    PubMed     Abstract available

  180. KARIMI M, Jooya P, Haghpanah S, Mokhtari M, et al
    Evaluation of the Relationship Between Hb F Levels and Nucleated Red Blood Cells with Morbidity in Non Transfusion-Dependent Thalassemia Patients.
    Hemoglobin. 2016;40:250-6.
    PubMed     Abstract available

  181. SINGH MP, Gupta RB, Yadav R, Sharma RK, et al
    Prevalence of alpha(+)-Thalassemia in the Scheduled Tribe and Scheduled Caste Populations of Damoh District in Madhya Pradesh, Central India.
    Hemoglobin. 2016;40:285-8.
    PubMed     Abstract available

    June 2016
  182. BELISARIO AR, Sales RR, Silva CM, Velloso-Rodrigues C, et al
    The Natural History of Hb S/Hereditary Persistence of Fetal Hemoglobin in 13 Children from the State of Minas Gerais, Brazil.
    Hemoglobin. 2016;40:215-9.
    PubMed     Abstract available

  183. YAN JM, Zhou JY, Xie XM, Li J, et al
    A New delta-Globin Gene Variant: Hb A2-Fengshun [delta121(GH4)Glu-->Lys (HBD: c.364G > A)].
    Hemoglobin. 2016;40:213-4.
    PubMed     Abstract available

  184. BUI THI KIM L, Phu Chi D, Hoang Thanh C
    Spectrum of Common alpha-Globin Deletion Mutations in the Southern Region of Vietnam.
    Hemoglobin. 2016;40:206-7.
    PubMed     Abstract available

  185. JIANG H, Yan JM, Li J, Xie XM, et al
    Diagnostic Dilemma of Hb Perth [beta32(B14)Leu-->Pro; HBB: c.98T > C] in Mainland China.
    Hemoglobin. 2016;40:202-5.
    PubMed     Abstract available

  186. PARMEGGIANI G, Gualandi F, Selvatici R, Rimessi P, et al
    A Family with gamma-Thalassemia and High Hb A2 Levels.
    Hemoglobin. 2016;40:187-90.
    PubMed     Abstract available

  187. MIRI-MOGHADDAM E, Bahrami S, Naderi M, Bazi A, et al
    Molecular Characterization of beta-Thalassemia Intermedia in Southeast Iran.
    Hemoglobin. 2016;40:173-8.
    PubMed     Abstract available

  188. MUNKONGDEE T, Tanakulmas J, Butthep P, Winichagoon P, et al
    Molecular Epidemiology of Hemoglobinopathies in Cambodia.
    Hemoglobin. 2016;40:163-7.
    PubMed     Abstract available

  189. MAXIMO C, Olalla Saad ST, Thome E, Queiroz AM, et al
    Amputations in Sickle Cell Disease: Case Series and Literature Review.
    Hemoglobin. 2016;40:150-5.
    PubMed     Abstract available

  190. YUZBASIOGLU ARIYUREK S, Yildiz SM, Yalin AE, Guzelgul F, et al
    Hemoglobinopathies in the Cukurova Region and Neighboring Provinces.
    Hemoglobin. 2016;40:168-72.
    PubMed     Abstract available

  191. ZHENG CY, Minniti CP, Chaitowitz MH
    Sickle Cell Crisis Complicated by Synthetic Cannabinoid Abuse: A Case Report.
    Hemoglobin. 2016;40:220-2.
    PubMed     Abstract available

  192. DIVOKA M, Partschova M, Kucerova J, Mojzikova R, et al
    Molecular Characterization of beta-Thalassemia in the Czech and Slovak Populations: Mediterranean, Asian and Unique Mutations.
    Hemoglobin. 2016;40:156-62.
    PubMed     Abstract available

  193. ZHOU JY, Yan JM, Li J, Li DZ, et al
    First Case of a Compound Heterozygosity for Two Nondeletional alpha-Thalassemia mutations, Hb Constant Spring and Hb Quong Sze.
    Hemoglobin. 2016;40:210-2.
    PubMed     Abstract available

  194. HAN L, Su H, Wu H, Jiang W, et al
    Molecular Epidemiological Survey of Glucose-6-Phosphate Dehydrogenase Deficiency and Thalassemia in Uygur and Kazak Ethnic Groups in Xinjiang, Northwest China.
    Hemoglobin. 2016;40:179-86.
    PubMed     Abstract available

  195. LI J, Yan JM, Xie XM, Zhou JY, et al
    Consequences of Delayed Prenatal Diagnosis of beta-Thalassemia in Mainland China.
    Hemoglobin. 2016;40:191-3.
    PubMed     Abstract available

    January 2016
  196. WU MY, Li DZ
    The Codon 35 (A > G) (HBB: c.107A > G) at the alpha-beta Chain Interface of the beta-Globin Gene: A Silent Mutation?
    Hemoglobin. 2016;40:56-8.
    PubMed     Abstract available

  197. KORDAFSHARI A, Amirian A, Zeinali S, Valaei A, et al
    Molecular Characterization of delta-Thalassemia in Iran.
    Hemoglobin. 2016;40:44-7.
    PubMed     Abstract available

  198. GATIN L, Rogier de Mare A, Mary P, Vialle R, et al
    Osteonecrosis of the Femoral Head: A Proposed New Treatment in Homozygous Sickle Cell Disease.
    Hemoglobin. 2016;40:1-9.
    PubMed     Abstract available

  199. YANG Y, He P, Li DZ
    Analysis of Fetal Blood: Is There Still a Role for Prenatal Diagnosis of Thalassemia?
    Hemoglobin. 2016;40:29-31.
    PubMed     Abstract available

  200. GHARTEY-KWANSAH G, Boampong JN, Aboagye B, Afoakwah R, et al
    The Prevalence of alpha-Thalassemia and Its Relation to Plasmodium falciparum Infection in Patients Presenting to Clinics in Two Distinct Ecological Zones in Ghana.
    Hemoglobin. 2016;40:32-7.
    PubMed     Abstract available

  201. UGRIN M, Stojiljkovic M, Zukic B, Klaassen K, et al
    Functional Analysis of an (A)gamma-Globin Gene Promoter Variant (HBG1: g.-225_-222delAGCA) Underlines Its Role in Increasing Fetal Hemoglobin Levels Under Erythropoietic Stress.
    Hemoglobin. 2016;40:48-52.
    PubMed     Abstract available

  202. SURAPOLCHAI P, Sirachainan N, So CC, Hongeng S, et al
    Curative Stem Cell Transplantation for Severe Hb H Disease Manifesting From Early Infancy: Phenotypic and Genotypic Analyses.
    Hemoglobin. 2016;40:70-3.
    PubMed     Abstract available

  203. AU PK, Kan AS, Tang MH, Leung KY, et al
    A Fetus with Hb Bart's Disease Due to Maternal Uniparental Disomy for Chromosome 16.
    Hemoglobin. 2016;40:66-9.
    PubMed     Abstract available

  204. WU MY, Li DZ
    First Detection of the -27 (A > G) (HBB: c.-77A > G) Mutation of the beta-Globin Gene in a Chinese Family.
    Hemoglobin. 2016;40:59-60.
    PubMed     Abstract available

  205. FARASHI S, Vakili S, Garous NF, Ashki M, et al
    Identification of Mutations Causing Aberrant Termination and Deficient Splice Donor Site on the HBA1 Gene.
    Hemoglobin. 2016;40:38-43.
    PubMed     Abstract available

  206. SMITH DL, Mitui M, Park JY, Luu HS, et al
    Characterization of the HBB: c.*233G > C Variant: No Evidence of a beta-Thalassemic Phenotype.
    Hemoglobin. 2016;40:25-8.
    PubMed     Abstract available

  207. SILVA AN, Cardoso GL, Cunha DA, Diniz IG, et al
    The Spectrum of beta-Thalassemia Mutations in a Population from the Brazilian Amazon.
    Hemoglobin. 2016;40:20-4.
    PubMed     Abstract available

  208. AKINBAMI AO, Campbell AD, Han ZJ, Luo HY, et al
    Hereditary Persistence of Fetal Hemoglobin Caused by Single Nucleotide Promoter Mutations in Sickle Cell Trait and Hb SC Disease.
    Hemoglobin. 2016;40:64-5.
    PubMed     Abstract available

  209. SMELTZER MP, Nolan VG, Yu X, Nottage KA, et al
    Distance from an Urban Sickle Cell Center and its Effects on Routine Healthcare Management and Rates of Hospitalization.
    Hemoglobin. 2016;40:10-5.
    PubMed     Abstract available

  210. LI YQ, Ye LH, Mo Y
    Hb Matera (HBB: c.167 T > A): A Second Case Detected in a Pregnant Chinese Woman by the Capillary Electrophoresis Method.
    Hemoglobin. 2016;40:125-6.
    PubMed     Abstract available

  211. KHOSRAVI A, Jalali-Far M, Saki N, Hosseini H, et al
    Evaluation of alpha-Globin Gene Mutations Among Different Ethnic Groups in Khuzestan Province, Southwest Iran.
    Hemoglobin. 2016;40:113-7.
    PubMed     Abstract available

  212. ZHENG X, Lin M, Yang H, Pan MC, et al
    Molecular Epidemiological Characterization and Health Burden of Thalassemias in the Chaoshan Region, People's Republic of China.
    Hemoglobin. 2016;40:138-42.
    PubMed     Abstract available

  213. OLIVEIRA A, Warcel D, Huntley N, Eleftheriou P, et al
    Symptomatic Erythrocytosis Due to Homozygosity for Hb Luton [HBA2: c.269A>T (or HBA1)] and alpha-Thalassemia: A Clinical Update.
    Hemoglobin. 2016;40:127-9.
    PubMed     Abstract available

  214. FARASHI S, Rad F, Shahmohammadi B, Imanian H, et al
    First Report of a Dominantly Inherited beta-Thalassemia Caused by a Novel Elongated beta-Globin Chain.
    Hemoglobin. 2016;40:102-7.
    PubMed     Abstract available

  215. ALKHALDI SM, Khatatbeh MM, Berggren VE, Taha HA, et al
    Knowledge and Attitudes Toward Mandatory Premarital Screening Among University Students in North Jordan.
    Hemoglobin. 2016;40:118-24.
    PubMed     Abstract available

  216. CHERRY L, Calo C, Talmaci R, Perrin P, et al
    beta-Thalassemia Haplotypes in Romania in the Context of Genetic Mixing in the Mediterranean Area.
    Hemoglobin. 2016;40:85-96.
    PubMed     Abstract available

  217. COLLIER AB 3RD, Coon LM, Monteleone P, Umaru S, et al
    A Novel beta-Globin Chain Hemoglobin Variant, Hb Allentown [beta137(H15)Val-->Trp (GTG>TGG) HBB: c.412_413delinsTG, p.Val138Trp], Associated with Low Oxygen Saturation, Intermittent Aplastic Crises and Splenomegaly.
    Hemoglobin. 2016;40:130-3.
    PubMed     Abstract available

  218. HENDERSON SJ, Timbs AT, McCarthy J, Gallienne AE, et al
    Ten Years of Routine alpha- and beta-Globin Gene Sequencing in UK Hemoglobinopathy Referrals Reveals 60 Novel Mutations.
    Hemoglobin. 2016;40:75-84.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Anemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.